CKD-385
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
May 28, 2021
Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
(clinicaltrials.gov)
- P1; N=52; Not yet recruiting; Sponsor: Chong Kun Dang Pharmaceutical
Clinical • New P1 trial • Cardiovascular
May 28, 2021
Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
(clinicaltrials.gov)
- P1; N=52; Not yet recruiting; Sponsor: Chong Kun Dang Pharmaceutical
Clinical • New P1 trial • Cardiovascular
December 21, 2020
Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
(clinicaltrials.gov)
- P1; N=24; Enrolling by invitation; Sponsor: Chong Kun Dang Pharmaceutical
Clinical • New P1 trial • Cardiovascular
December 03, 2020
Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
(clinicaltrials.gov)
- P1; N=24; Enrolling by invitation; Sponsor: Chong Kun Dang Pharmaceutical
Clinical • New P1 trial • Cardiovascular
February 05, 2020
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
(clinicaltrials.gov)
- P1; N=16; Completed; Sponsor: Chong Kun Dang Pharmaceutical; Recruiting ➔ Completed
Clinical • Trial completion
February 05, 2020
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
(clinicaltrials.gov)
- P1; N=24; Completed; Sponsor: Chong Kun Dang Pharmaceutical; Recruiting ➔ Completed
Clinical • Trial completion
February 05, 2020
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers
(clinicaltrials.gov)
- P1; N=52; Completed; Sponsor: Chong Kun Dang Pharmaceutical; Recruiting ➔ Completed
Clinical • Trial completion
1 to 7
Of
7
Go to page
1